- Home
- FER vs RGC Comparison
FER vs RGC Comparison
Compare FER & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FER
- RGC
- Stock Information
- Founded
- FER 1952
- RGC 2014
- Country
- FER Netherlands
- RGC Hong Kong
- Employees
- FER N/A
- RGC N/A
- Industry
- FER
- RGC Medicinal Chemicals and Botanical Products
- Sector
- FER
- RGC Health Care
- Exchange
- FER NYSE
- RGC Nasdaq
- Market Cap
- FER 38.4B
- RGC 38.6B
- IPO Year
- FER N/A
- RGC 2021
- Fundamental
- Price
- FER $51.18
- RGC $12.97
- Analyst Decision
- FER
- RGC
- Analyst Count
- FER 0
- RGC 0
- Target Price
- FER N/A
- RGC N/A
- AVG Volume (30 Days)
- FER 178.1K
- RGC 1.2M
- Earning Date
- FER 07-29-2025
- RGC 06-30-2025
- Dividend Yield
- FER 1.74%
- RGC N/A
- EPS Growth
- FER 340.64
- RGC N/A
- EPS
- FER 5.48
- RGC N/A
- Revenue
- FER $10,979,448,033.00
- RGC N/A
- Revenue This Year
- FER $5.83
- RGC N/A
- Revenue Next Year
- FER $3.83
- RGC N/A
- P/E Ratio
- FER $9.24
- RGC N/A
- Revenue Growth
- FER 5.75
- RGC N/A
- 52 Week Low
- FER $37.93
- RGC $0.09
- 52 Week High
- FER $56.43
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- FER N/A
- RGC 43.66
- Support Level
- FER N/A
- RGC $13.11
- Resistance Level
- FER N/A
- RGC $14.80
- Average True Range (ATR)
- FER 0.00
- RGC 1.43
- MACD
- FER 0.00
- RGC -0.01
- Stochastic Oscillator
- FER 0.00
- RGC 3.72
About FER FERROVIAL SE
Ferrovial SE is a Spanish industrial company. The company organizes itself into four segments: Toll Roads, Airports, Construction, and Energy. The Toll Roads segment develops and operates toll roads globally. The Airports segment includes the development, financing and operation of airports. The Construction segment designs and executes all public and private works, including most notably the construction of public infrastructures. The Energy segment focuses on innovative solutions for promoting, constructing and operating energy generation and transmission infrastructures.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.